======= SLC30A9 ======= == Gene Information == * **Official Symbol**: SLC30A9 * **Official Name**: solute carrier family 30 member 9 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10463|10463]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q6PML9|Q6PML9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SLC30A9&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SLC30A9|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604604|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Acts as a zinc transporter involved in intracellular zinc homeostasis (PubMed:28334855). Functions as a secondary coactivator for nuclear receptors by cooperating with p160 coactivators subtypes. Plays a role in transcriptional activation of Wnt-responsive genes (By similarity). {ECO:0000250|UniProtKB:Q5IRJ6, ECO:0000269|PubMed:28334855}. |Cation efflux| |cation transmembrane transporter activity| |nuclear receptor binding| |zinc ion transport| |cellular zinc ion homeostasis| |zinc ion homeostasis| |nuclear receptor transcription coactivator activity| |cellular transition metal ion homeostasis| |nucleotide-excision repair| |transition metal ion transport| |transition metal ion homeostasis| |cytoplasmic vesicle| |divalent metal ion transport| |divalent inorganic cation transport| |cytoskeleton| |chromatin binding| |cellular divalent inorganic cation homeostasis| |divalent inorganic cation homeostasis| |DNA repair| |cellular metal ion homeostasis| |cation transmembrane transport| |metal ion homeostasis| |cellular cation homeostasis| |metal ion transport| |cellular ion homeostasis| |DNA-binding transcription factor activity| |cation homeostasis| |inorganic ion homeostasis| |cellular chemical homeostasis| |DNA metabolic process| |cellular response to DNA damage stimulus| |ion homeostasis| |cation transport| |cellular homeostasis| |ion transmembrane transport| |endoplasmic reticulum| |chemical homeostasis| |positive regulation of transcription by RNA polymerase II| |transmembrane transport| |ion transport| |positive regulation of transcription, DNA-templated| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |homeostatic process| |cellular response to stress| |positive regulation of RNA metabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|-1.87| |[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|1.7| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|1.71| |[[:results:exp243|S-trityl-L-cysteine 0.5μM R05 exp243]]|1.72| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|1.74| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|1.78| |[[:results:exp59|UMK57 1μM R01 exp59]]|1.81| |[[:results:exp230|Epigallocatechin gallate 20μM R05 exp230]]|1.86| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|1.89| |[[:results:exp32|Rifampicin 10μM R00 exp32]]|1.96| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|2| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|2.18| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|2.52| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|2.86| ^Gene^Correlation^ |[[:human genes:x:xpnpep3|XPNPEP3]]|0.48| |[[:human genes:p:pde12|PDE12]]|0.477| |[[:human genes:m:mpv17l2|MPV17L2]]|0.464| |[[:human genes:d:ddx28|DDX28]]|0.425| |[[:human genes:t:timm8a|TIMM8A]]|0.416| |[[:human genes:p:prepl|PREPL]]|0.413| |[[:human genes:c:cox6a1|COX6A1]]|0.412| |[[:human genes:m:micu2|MICU2]]|0.411| |[[:human genes:m:mtif2|MTIF2]]|0.41| |[[:human genes:e:eral1|ERAL1]]|0.408| |[[:human genes:c:clpx|CLPX]]|0.405| |[[:human genes:f:fastkd2|FASTKD2]]|0.4| |[[:human genes:c:clpp|CLPP]]|0.4| Global Fraction of Cell Lines Where Essential: 6/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|1/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 194 * **Expression level (log2 read counts)**: 5.09 {{:chemogenomics:nalm6 dist.png?nolink |}}